2005, Number 1
<< Back Next >>
Acta Med 2005; 3 (1)
Levels of glycosylated hemoglobin in patients with acute myocardial infarction with and without a previous diabetes mellitus diagnosis
Juárez BMC, González BD, Antonio Ramos CMA, Valles SVE, Jiménez RCM
Language: Spanish
References: 21
Page: 25-32
PDF size: 133.03 Kb.
ABSTRACT
Aim: To evaluate serum glycated hemoglobin levels in patients with acute
myocardial infarction with and without previously known diabetes.
Material
and methods: Seventy one patients with acute myocardial infarction with and
without previously known diabetes were assessed respect to glucose, cholesterol,
high density lipoproteins (HDL), low density lipoproteins (LDL), triglycerides,
creatin kinase, glycated hemoglobin (HbA
1c) and
uric acid.
Results: Seventy one patients (51 men and 14 women), 38 known
as diabetics (27 men and 11 women) and 33 (30 men and 3 woman) without previously
known diabetes, the range of age was 56 and 64 years old respectively. Mean levels
of hemoglobin A
1c was 11.62%
for diabetics and 7.93% for those without previously known diabetes. Its important
to note that 22 (66.6%) from patients without previously known diabetes had values
higher than 7%. There was not a significant difference between both groups in
the mean values of total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides,
uric acid, creatin kinase and glycated hemoglobin.
Conclusion: Levels of
glycated hemoglobin may serve as predictor of cardiovascular risk in patients
without previously known diabetes. Key words: Glycated hemoglobin , myocardial
infarction, diabetes mellitus.
REFERENCES
Hirsch I. Editorial: In-Patient Hyperglycemia-Are We Ready to Treat It Yet. J Clin Endocrinol Metab 2002; 87: 975-977.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2004; 27: S5-S10.
The DECODE Study Group. Glucose tolerance and Mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-621.
Roth M. Glycated hemoglobin, not glycoylated or glycosilated. Clinical Chemistry 1983; 29: 1991.
Mayer T et al. Protein glycosylation in diabetes mellitus. A review of laboratory measurements. Clin Chem Acta 1983; 127: 147-184.
Engbaek, Frode et al. Enzyme immunoassay of hemoglobin A1c: Analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia. Clin Chem Acta 1989; 351: 93-97.
Khaw KT, Waream N, Luben R, Bingham S et al. Glycated Haemoglobin, diabetes and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). Br Med J 2001; 322: 15-20.
Reaven GM, Banting. Lecture 1988: Role of insulin resistance in human disease. Diabetes 1988; 37: 1095-1607.
DeFronzo RA, Ferranini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dislipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
Barret-Connor E, Wingard DL “Normal” blood glucose and coronary risk. Dose response effect seems consistent throughout the glycaemic continuum. Br Med J 2001; 322: 5-6.
Hanley A, Williams K, Gonzalez C, D’Agostino JR, Wagenknecht L et al. Prediction of Type 2 Diabetes Using Simple Measures of Insulin Resistance: Combined Results From the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003; 52: 463-469.
Haller H. Postprandial glucose and vascular disease. Diabetic Medicine 1997; 14: S50-S56.
Consenso Mexicano sobre el Tratamiento Integral del Síndrome Metabólico. Rev Mex Cardiol 2002; 13: 4-30.
Capes SE, Hunt D, Malmberg K, Gerstein H. Stress hyperglycemia and increased risk of death alter myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-778.
Capes SE, Hunt D, Malmberg K, Phathak P, Gerstein H. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-2432.
Encuesta Nacional de México (ENSA-2000). Secretaría de Salud, México, D.F.
Narayan KMV, Gregg EW, Engelgau MM, Moore B, Thompson TJ, et al. Translation research for chronic disease: the case of diabetes. Diabetes Care 2000; 23: 1794-1798.
Davidson J. ¿Se debería medir y tartar la glucosa postprandial hasta alcanzar un valor en particular? Sí. Diabetes Care 2003; 26: 1-3.
Weiss R, Dziura J, Burgert T, Tamborlane W, Taksali S et al. Obesity and the Metabolic Syndrome in Children and Adolescents. N Engl J Med 2004; 350: 2362-2374.
Hernández B, Cuevas-Nasu L, Shamah-Levy T, Monterrubio EA, Ramirez-Silva C. Factores asociados con sobrepeso y obesidad en niños mexicanos de edad escolar: resultados de la Encuesta Nacional de Nutrición 1999. Salud Pública Mex 2003; 45 supl 4: S551-S557.
Dirección general de Epidemiología SSA. INNSC. Encuesta Nacional de Enfermedades Crónicas. México. Secretaría de Salud 1993.
Full text